-transparent.png){kind=logo}
Cyclosporin A (CsA) was assessed for its effect on the production of antiviral activity by human peripheral blood leukocytes (PBL). CsA markedly reduced the production of interferon-gamma (IFN-gamma) in response to stimulation with lectin mitogens, bacterial products, alloantigens, or Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCL). CsA-mediated suppression of IFN-gamma secretion was dose-dependent and did not result from a shift of kinetics of the production of antiviral activity. The production of IFN-alpha in response to stimulation with Corynebacterium parvum (CP), viruses, and synthetic polynucleotides was not affected by the addition of CsA. These findings confirm earlier observations that CsA predominantly acts on T lymphocyte function. CsA may prove a valuable agent to study the role of IFN-gamma in the pathogenesis of virus-associated malignant lymphoproliferative disease.
J Abb, and
H Abb, and
F Deinhardt
March 1983,
Cancer research,
J Abb, and
H Abb, and
F Deinhardt
August 1977,
Cellular immunology,
J Abb, and
H Abb, and
F Deinhardt
January 1966,
Annales medicinae experimentalis et biologiae Fenniae,
J Abb, and
H Abb, and
F Deinhardt
February 1985,
Antiviral research,
J Abb, and
H Abb, and
F Deinhardt
April 1979,
The Journal of clinical endocrinology and metabolism,
J Abb, and
H Abb, and
F Deinhardt
March 1995,
Experimental hematology,
J Abb, and
H Abb, and
F Deinhardt
November 1986,
Journal of immunological methods,
J Abb, and
H Abb, and
F Deinhardt
November 1969,
Applied microbiology,
J Abb, and
H Abb, and
F Deinhardt
March 1969,
Cancer research,
J Abb, and
H Abb, and
F Deinhardt
January 1993,
Life sciences,
